Plandai Biotechnology, Inc. Delivers on First Purchase Order of Green Tea Extract to USN

Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí” or “the Company”), producer of the highly bioavailable Phytofare® Catechin Complex, today announced that it filled its first purchase order from USN Worldwide as part of the Company’s exclusive 3-year agreement to supply USN with commercial amounts of the Company’s flagship green tea extract.

Callum Baylis-Duffield, Vice President of Sales and Marketing for Plandaí, said, “We filled and delivered on what we expect to be the first of many purchase orders in our exclusive deal with the sports nutrition brand, USN. After many years of hard work, this deal validates our impressive clinical trial results. Companies like USN not only recognize the importance of our data from clinical trials, but they also see the benefit to offering a highly bioavailable great tea extract to their customers.”

Estie Mertz, Customer Relationship Manager for Azochem Laboratories, a contract manufacturer for USN, said of the delivery, “We'd...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://money.cnn.com/news/newsfeeds/articles/marketwire/11G042310-001.htm